APA

Oentrich W., Dose T., Friedmann D., Haupts M., Haller P., Hartung H. P., Walther E. U., König N., Schröder G. & Stürzebecher C. S. (20010607). [Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression]. : Der Nervenarzt.

Chicago

Oentrich W, Dose T, Friedmann D, Haupts M, Haller P, Hartung H P, Walther E U, König N, Schröder G and Stürzebecher C S. 20010607. [Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression]. : Der Nervenarzt.

Harvard

Oentrich W., Dose T., Friedmann D., Haupts M., Haller P., Hartung H. P., Walther E. U., König N., Schröder G. and Stürzebecher C. S. (20010607). [Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression]. : Der Nervenarzt.

MLA

Oentrich W, Dose T, Friedmann D, Haupts M, Haller P, Hartung H P, Walther E U, König N, Schröder G and Stürzebecher C S. [Interferon beta-1b (Betaferon)therapy in patients with relapsing-remitting multiple sclerosis: findings of a prospective, multi-center study of disease progression]. : Der Nervenarzt. 20010607.